Dr. Mariola Söhngen Chief Executive Officer and Executive Director, Proteome Sciences 00:00:00
Mariola Söhngen has established a strong and successful career in the pharmaceutical industry both in the US and Europe. She was a co-founder of Paion AG which developed a clinical-stage asset for the treatment of stroke and subsequently delivered a novel anaesthetic that received FDA approval in 2020.